Varonis (VRNS) Form 144: 56,940 Shares Proposed Sale $3.33M
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Notice of Proposed Sale under Rule 144: This Form 144 reports a proposed sale of 56,940 common shares of Varonis Systems, Inc. (VRNS) with an aggregate market value of $3,332,128.80, using Morgan Stanley Smith Barney LLC as broker and an approximate sale date of 08/22/2025. The shares were acquired as Performance Stock Units on 02/29/2024. The filing shows 112,047,109 shares outstanding. The record also lists two 10b5-1 sales by Guy Melamed within the past three months: 42,705 shares sold on 08/13/2025 for $2,465,133.31 and 51,889 shares sold on 08/01/2025 for $2,859,281.08. The filer attests to Rule 10b5-1 representations and confirms no undisclosed material adverse information.
Positive
- Acquisition clearly disclosed: Shares were acquired as Performance Stock Units on 02/29/2024.
- Broker specified: Morgan Stanley Smith Barney LLC is named for the proposed transaction.
- Prior 10b5-1 sales disclosed: Two recent 10b5-1 sales (08/01/2025 and 08/13/2025) with gross proceeds are listed, increasing transparency.
Negative
- None.
Insights
TL;DR: Routine insider sale notice: 56,940 shares (~$3.33M) proposed for sale; recent 10b5-1 execution activity shown.
The filing is a standard Form 144 disclosure reporting a proposed sale of common stock by an insider or affiliate. Key facts are the share amount, aggregate market value, acquisition as performance stock units on 02/29/2024, and use of Morgan Stanley Smith Barney as broker. The form also documents recent 10b5-1 sale activity for the named seller on 08/01/2025 and 08/13/2025 with stated proceeds. This provides transparency about insider liquidity events but does not, by itself, convey operational or financial performance information about the issuer.
TL;DR: Compliance disclosure appears complete for a Rule 144 notice and references 10b5-1 plan sales; no disclosed material nonpublic information.
The document includes required elements for Rule 144 reporting: class of security, broker, number of shares, market value, outstanding shares, acquisition details, and prior three-month sales records. It states the seller's representation regarding absence of undisclosed material adverse information and references plan adoption/instruction dates related to 10b5-1 activity. The filing reads as a procedural disclosure to satisfy securities-law reporting obligations rather than a material corporate event.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filed for Varonis (VRNS) report?
Who is the broker handling the proposed VRNS sale?
Were there recent insider sales reported for VRNS in the past three months?
AI-generated analysis. How Rhea-AI works. Not financial advice.